K. M. Venkat Narayan
K. M. Venkat Narayan, MD, MSC, MBA, FRCP, a diabetes expert, is the founder and executive director of the Emory Global Diabetes Research Center (EGDRC). He is Ruth and O.C. Hubert Chair Global Health and Epidemiology at the Rollins School of Public Health.[1] He is also professor of medicine and endocrinology at the Emory University School of Medicine.[2]
Research
Narayan has been actively involved in advancing diabetes prevention and care strategies. His research informs evidence-based interventions aimed at reducing the global burden of diabetes.
He has played a pivotal role in conceptualizing and promoting diabetes translation research. This work bridges the gap between scientific discoveries and practical applications in clinical and public health settings.
Narayan's systematic documentation of type 2 diabetes in youth shed light on this growing public health concern. His findings emphasized the need for early prevention and effective management.[3]
He led the world's first assessment of lifetime risk for diabetes, providing critical insights into long-term health outcomes.[4] Narayan's models project the future burden of diabetes, guiding policymakers and healthcare professionals in planning effective interventions.
His research includes the first comprehensive study on the national incidence of childhood obesity,[5] highlighting the urgency of addressing this epidemic. Recently, Narayan has explored insulin-deficient phenotypes within type 2 diabetes. His investigations reveal intriguing differences across diverse populations, including those in Asia, Africa, Native America, and developing countries.[6][7]
Narayan currently leads (in collaboration with multiple partners) the P-CARRS Cohort of 22,000 South Asian people investigating cardiometabolic disease phenotypes, and the P-CARRS-BRAIN study investigating the connection between diabetes, vascular diseases, and dementia. He is also involved in the leadership of an endocrine pancreas biobank, and a Diabetes Technology Accelerator program to advance low-cost innovations to scale.[8]
Honors
Narayan is an elected member of the National Academy of Medicine (NAM)[9] and a foreign fellow of the Indian National Science Academy (INSA).[10] He received Kelly West award from the American Diabetes Association for outstanding achievements in epidemiology.[11][12]
References
- ^ "Kabayam Venkat Narayan". Rollins School of Public Health.
- ^ "K. M. Venkat Narayan, MD, MSc, MBA | EGDRC". Emory University.
- ^ "DEFEATING DIABETES". Emory.edu.
- ^ "'Shocking' Diabetes Prediction". CBS News. 14 June 2003.
- ^ "Changes in the Incidence of Childhood Obesity". Aap.org.
- ^ "Diabetes: From disease of affluent countries to global problem | Emory University | Atlanta GA". Emory.edu.
- ^ "DEFEATING DIABETES". Emory University.
- ^ https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.15373?doi=10.1161/HYPERTENSIONAHA.120.15373
- ^ "National Academy of Medicine elects Emory nursing, public health researchers". Emory University.
- ^ "Venkat Narayan elected Foreign Fellow by INSA". Khabar Magazine.
- ^ "K.M. Venkat Narayan, MD, MSc, MBA, FRCP, Receives American Diabetes Association's Kelly West Award For Outstanding Achievement In Epidemiology". BioSpace. 29 April 2015.
- ^ "Kelly West Award for Outstanding Achievement in Epidemiology". American Diabetes Association.
External links
- K. M. Venkat Narayan publications indexed by Google Scholar